(Q38466338)

3 September 2017

title

Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint scintiscans (English)

1 reference

3 September 2017

1 reference

Murphy GP

1

1 reference

3 September 2017

Snow PB

2

1 reference

3 September 2017

Brandt J

3

1 reference

3 September 2017

Elgamal A

4

1 reference

3 September 2017

Brawer MK

5

1 reference

3 September 2017

publication date

1 February 2000

1 reference

3 September 2017

1 reference

3 September 2017

volume

42

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

145-149

1 reference

Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Measurement of complexed PSA improves specificity for early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Basic principles of ROC analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

The perceptron: a probabilistic model for information storage and organization in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

Artificial Neural Networks in the Diagnosis and Prognosis of Prostate Cancer: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C145%3A%3AAID-PROS9%3E3.0.CO%3B2-Q

10.1002/(SICI)1097-0045(20000201)42:2<145::AID-PROS9>3.0.CO;2-Q

21 January 2018

Identifiers

DOI

1 reference

release_nyio23egfng3xkhdrrbqwnydtq

3 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nyio23egfng3xkhdrrbqwnydtq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference